Araştırma Makalesi
BibTex RIS Kaynak Göster

Bibliometric Analysis of Studies on the Relationship between COVID-19 Vaccines and Myocarditis

Yıl 2025, Cilt: 47 Sayı: 3, 430 - 437, 02.05.2025
https://doi.org/10.20515/otd.1554684

Öz

In this study, a bibliometric analysis of the worldwide trends of studies on the relationship between COVID-19 vaccines and myocarditis was performed. This bibliometric study investigates the studies on the relationship between COVID-19 vaccines and myocarditis conducted worldwide between the years 2020-2023. For this purpose, 746 studies were examined as a result of searches made in Web of Science and Scopus databases. For data collection, information such as title, author names, publication year, journal name and number of citations were used. All text data are analyzed with “VOSviewer software” to ensure accuracy and reliability. In this study, analyses using text mining and data visualization methods (eg bubble maps) helped to make the results more understandable. In this article, information is given about 733 articles from Web of Science and Scopus databases and 11797 citations to these articles. The average number of citations per article is 16 and the H index is 45. As of 2021, both the number of articles and the number of citations have increased. Almost all of the articles have been published in the cardiovascular system and other health sciences. The USA, Italy, England and Japan are the countries that published the most articles (54%) on this subject. Most of the articles (79%) are in the SCI-Expanded category. The findings we obtained in our study show that many researchers are active in studies on the relationship between COVID-19 vaccines and myocarditis and that the research in this field is increasing.

Kaynakça

  • 1. Okor I, Bob-Manuel T, Price J, Sleem A, Amoran O, Kelly J, Ekerete MF, Bamgbose MO, Bolaji OA, Krim SR. COVID-19 Myocarditis: An Emerging Clinical Conundrum. Curr Probl Cardiol. 2022: Sep; 47(9):101268.
  • 2. Alqahtani MS, Abbas M, Alsabaani A, Alqarni A, Almohiy HM, Alsawqaee E, Alshahrani R, Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect Drug Resist. 2022 Mar 22; 15: 1175-1189.
  • 3. Kornowski R, Witberg G. Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination. Open Heart, 2022: 9(1), e001957.
  • 4. World Health Organization. Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness. World Health Organization. 2021
  • 5. Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Aff (Millwood). 2021: Jan; 40(1): 42-52. 6. Organisation for Economic Co-operation and Development. Enhancing public trust in COVID-19 vaccination: The role of governments. OECD Publishing. 2021.
  • 7. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021. Aug 10; 144(6): 471-484.
  • 8. Ali M, Shiwani HA, Elfaki MY, Hamid M, Pharithi R, Kamgang R, Egom CB, Oyono JLE, Egom EE. COVID-19 and myocarditis: a review of literature. Egypt Heart J. 2022. Apr 5; 74(1): 23.
  • 9. Barreiro-Pérez M, Pueyo PP, Raposeiras-Roubín S, Corominas DM, Uribarri A, Bachiller RE, Figal DP. Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. Revista Española de Cardiología (English Edition). 2023.
  • 10. Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschöpe C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, Imazio M, Prasad S, Lüscher TF. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2022: Nov; 24(11): 2000-2018.
  • 11. Khan Z, Pabani UK, Gul A, Muhammad SA, Yousif Y, Abumedian M, Elmahdi O, Gupta A. COVID-19 Vaccine-Induced Myocarditis: A Systemic Review and Literature Search. Cureus. 2022. Jul 28; 14(7): e27408.
  • 12. Morgan MC, Atri L, Harrell S, Al-Jaroudi W, Berman A. COVID-19 vaccine-associated myocarditis. World J Cardiol. 2022. Jul 26; 14(7): 382-391.
  • 13. Shaheen N, Ramadan A, Shaheen A, Elmasry M, Swed S, Hafez W, Hafez Sr W. Myocarditis Following COVID-19 Vaccination: A Systematic Review. Cureus. 2023. April 22. 15(4): e37999.

COVID-19 Aşıları ile Miyokardit Arasındaki İlişkiye Dair Çalışmaların Bibliyometrik Analizi

Yıl 2025, Cilt: 47 Sayı: 3, 430 - 437, 02.05.2025
https://doi.org/10.20515/otd.1554684

Öz

Bu çalışmada, COVID-19 aşıları ile miyokardit arasındaki ilişkiye dair dünya çapındaki çalışmaların eğilimlerinin bibliyometrik analizi yapılmıştır. Bu bibliyometrik çalışma, 2020-2023 yılları arasında dünya çapında COVID-19 aşıları ile miyokardit arasındaki ilişkiye dair yapılan çalışmaları incelemektedir. Bu amaçla, Web of Science ve Scopus veri tabanlarında yapılan taramalar sonucunda 746 çalışma incelenmiştir. Veri toplamada, başlık, yazar adları, yayın yılı, dergi adı ve atıf sayısı gibi bilgiler kullanılmıştır. Tüm metin verileri, doğruluk ve güvenilirliği sağlamak için “VOSviewer yazılımı” ile analiz edilmiştir. Bu çalışmada, metin madenciliği ve veri görselleştirme yöntemleri (örneğin kabarcık haritaları) kullanılarak yapılan analizler, sonuçların daha anlaşılır olmasına yardımcı olmuştur. Bu makalede, Web of Science ve Scopus veri tabanlarından alınan 733 makale ve bu makalelere yapılan 11797 atıf hakkında bilgi verilmektedir. Makale başına düşen atıf sayısı ortalaması 16 olup H indeksi 45'tir. 2021 yılı itibariyle hem makale sayısı hem de atıf sayısı artmıştır. Makalelerin neredeyse tamamı kardiyovasküler sistem ve diğer sağlık bilimleri alanında yayınlanmıştır. Bu konuda en fazla makale yayınlayan ülkeler ABD, İtalya, İngiltere ve Japonya'dır (%54). Makalelerin çoğu (%79) SCI-Expanded kategorisindedir. Çalışmamızda elde ettiğimiz bulgular, birçok araştırmacının COVID-19 aşıları ile miyokardit arasındaki ilişki üzerine çalışmalarda aktif olduğunu ve bu alandaki araştırmaların arttığını göstermektedir.

Kaynakça

  • 1. Okor I, Bob-Manuel T, Price J, Sleem A, Amoran O, Kelly J, Ekerete MF, Bamgbose MO, Bolaji OA, Krim SR. COVID-19 Myocarditis: An Emerging Clinical Conundrum. Curr Probl Cardiol. 2022: Sep; 47(9):101268.
  • 2. Alqahtani MS, Abbas M, Alsabaani A, Alqarni A, Almohiy HM, Alsawqaee E, Alshahrani R, Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect Drug Resist. 2022 Mar 22; 15: 1175-1189.
  • 3. Kornowski R, Witberg G. Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination. Open Heart, 2022: 9(1), e001957.
  • 4. World Health Organization. Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness. World Health Organization. 2021
  • 5. Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Aff (Millwood). 2021: Jan; 40(1): 42-52. 6. Organisation for Economic Co-operation and Development. Enhancing public trust in COVID-19 vaccination: The role of governments. OECD Publishing. 2021.
  • 7. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021. Aug 10; 144(6): 471-484.
  • 8. Ali M, Shiwani HA, Elfaki MY, Hamid M, Pharithi R, Kamgang R, Egom CB, Oyono JLE, Egom EE. COVID-19 and myocarditis: a review of literature. Egypt Heart J. 2022. Apr 5; 74(1): 23.
  • 9. Barreiro-Pérez M, Pueyo PP, Raposeiras-Roubín S, Corominas DM, Uribarri A, Bachiller RE, Figal DP. Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. Revista Española de Cardiología (English Edition). 2023.
  • 10. Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschöpe C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, Imazio M, Prasad S, Lüscher TF. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2022: Nov; 24(11): 2000-2018.
  • 11. Khan Z, Pabani UK, Gul A, Muhammad SA, Yousif Y, Abumedian M, Elmahdi O, Gupta A. COVID-19 Vaccine-Induced Myocarditis: A Systemic Review and Literature Search. Cureus. 2022. Jul 28; 14(7): e27408.
  • 12. Morgan MC, Atri L, Harrell S, Al-Jaroudi W, Berman A. COVID-19 vaccine-associated myocarditis. World J Cardiol. 2022. Jul 26; 14(7): 382-391.
  • 13. Shaheen N, Ramadan A, Shaheen A, Elmasry M, Swed S, Hafez W, Hafez Sr W. Myocarditis Following COVID-19 Vaccination: A Systematic Review. Cureus. 2023. April 22. 15(4): e37999.
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Halk Sağlığı (Diğer)
Bölüm ORİJİNAL MAKALELER / ORIGINAL ARTICLES
Yazarlar

İzzet Çeleğen 0000-0002-2749-953X

Sadi Elasan 0000-0002-3149-6462

Abdullah Sarıöz 0000-0003-1512-3532

Yayımlanma Tarihi 2 Mayıs 2025
Gönderilme Tarihi 23 Eylül 2024
Kabul Tarihi 9 Nisan 2025
Yayımlandığı Sayı Yıl 2025 Cilt: 47 Sayı: 3

Kaynak Göster

Vancouver Çeleğen İ, Elasan S, Sarıöz A. Bibliometric Analysis of Studies on the Relationship between COVID-19 Vaccines and Myocarditis. Osmangazi Tıp Dergisi. 2025;47(3):430-7.


13299        13308       13306       13305    13307  1330126978